Africa’s pharma industry will double by 2020, says new report

18 June 2015
south-africa-big

Africa’s pharmaceutical industry jumped to $20.8 billion in 2013, up from just $4.7 billion a decade earlier, according to a new report from McKinsey & Company.

That growth is continuing at a rapid pace and report authors Tania Holt, Mehdi Lahrichi and Jorge Santos da Silva predict the market will be worth $40 billion to $65 billion by 2020. As developed markets stagnate, the authors conclude that the continent will be a good place for pharma companies seeking new sources of growth.

What’s driving growth

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical